{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:16:12Z","timestamp":1790507772972,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T00:00:00Z","timestamp":1403827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s10689-014-9733-4","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T11:56:01Z","timestamp":1403783761000},"page":"553-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Muir\u2013Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients"],"prefix":"10.1007","volume":"13","author":[{"given":"G.","family":"Ponti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pellacani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ruini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Percesepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Desmond","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Crucianelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tomasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,27]]},"reference":[{"key":"9733_CR1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(95)92780-8","volume":"346","author":"NJ London","year":"1995","unstructured":"London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP (1995) Risk of neoplasia in renal transplant patients. Lancet 346:403\u2013406","journal-title":"Lancet"},{"key":"9733_CR2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0190-9622(99)70185-4","volume":"40","author":"P Jensen","year":"1999","unstructured":"Jensen P, Hansen S, M\u00f8ller B, Leivestad T, Pfeffer P, Geiran O et al (1999) Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 40:177\u2013186","journal-title":"J Am Acad Dermatol"},{"key":"9733_CR3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0007-1226(94)90164-3","volume":"47","author":"MT Glover","year":"1994","unstructured":"Glover MT, Niranjan N, Kwan JT, Leigh IM (1994) Non-melanoma skin cancer in renal transplant recipients: the extent of the problem and a strategy for management. Br J Plast Surg 47:86\u201389","journal-title":"Br J Plast Surg"},{"key":"9733_CR4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1067\/mjd.2003.97","volume":"48","author":"CA Harwood","year":"2003","unstructured":"Harwood CA, McGregor JM, Swale VJ, Proby CM, Leigh IM, Newton R et al (2003) High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients. J Am Acad Dermatol 48:401\u2013408","journal-title":"J Am Acad Dermatol"},{"key":"9733_CR5","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1470-2045(05)70465-4","volume":"6","author":"G Ponti","year":"2005","unstructured":"Ponti G, Ponz de Leon M (2005) Muir\u2013Torre syndrome. Lancet Oncol 6:980\u2013987","journal-title":"Lancet Oncol"},{"key":"9733_CR6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.onc.1209758","volume":"26","author":"C Oliveira","year":"2007","unstructured":"Oliveira C, Velho S, Moutinho C, Ferreira A, Preto A, Domingo E et al (2007) KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene 26:158\u2013163","journal-title":"Oncogene"},{"key":"9733_CR7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1523-1747.2001.01233.x","volume":"116","author":"CA Harwood","year":"2001","unstructured":"Harwood CA, Swale VJ, Bataille VA, Quinn AG, Ghali L, Patel SV et al (2001) An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol 116:246\u2013253","journal-title":"J Invest Dermatol"},{"key":"9733_CR8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hon.751","volume":"23","author":"D Capello","year":"2005","unstructured":"Capello D, Rossi D, Gaidano G (2005) Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis. Hematol Oncol 23:61\u201367","journal-title":"Hematol Oncol"},{"key":"9733_CR9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1470-2045(03)00957-4","volume":"4","author":"A Carbone","year":"2003","unstructured":"Carbone A (2003) Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol 4:22\u201329","journal-title":"Lancet Oncol"},{"key":"9733_CR10","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1182\/blood-2002-11-3606","volume":"102","author":"G Gaidano","year":"2003","unstructured":"Gaidano G, Pasqualucci L, Capello D, Berra E, Deambrogi C, Rossi D et al (2003) Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood 102:1833\u20131841","journal-title":"Blood"},{"key":"9733_CR11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jaad.2010.08.003","volume":"65","author":"MN Landis","year":"2011","unstructured":"Landis MN, Davis CL, Bellus GA, Wolverton SE (2011) Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir\u2013Torre syndrome unmasked by immunosuppressive therapy. J Am Acad Dermatol 65:1054\u20131058","journal-title":"J Am Acad Dermatol"},{"key":"9733_CR12","first-page":"896","volume":"61","author":"M Pedroni","year":"2001","unstructured":"Pedroni M, Sala E, Scarselli A, Borghi F, Menigatti M, Benatti P et al (2001) Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res 61:896\u2013899","journal-title":"Cancer Res"},{"issue":"7","key":"9733_CR13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa064522","volume":"356","author":"MP Hitchins","year":"2007","unstructured":"Hitchins MP, Wong JJ, Suthers G, Suter CM, Martin DI, Hawkins NJ, Ward RL (2007) Inheritance of a cancer-associated MLH1 germ-line epimutation. N Engl J Med 356(7):697\u2013705","journal-title":"N Engl J Med"},{"key":"9733_CR14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ng.283","volume":"41","author":"MJ Ligtenberg","year":"2009","unstructured":"Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M et al (2009) Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3\u2032 exons of TACSTD1. Nat Genet 41:112\u2013117","journal-title":"Nat Genet"},{"key":"9733_CR15","first-page":"4836","volume":"56","author":"SN Thibodeau","year":"1996","unstructured":"Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM et al (1996) Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 56:4836\u20134840","journal-title":"Cancer Res"},{"issue":"18","key":"9733_CR16","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa043146","volume":"352","author":"H Hampel","year":"2005","unstructured":"Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352(18):1851\u20131860","journal-title":"N Engl J Med"},{"key":"9733_CR17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1155\/2004\/486032","volume":"20","author":"A Umar","year":"2004","unstructured":"Umar A (2004) Lynch syndrome (HNPCC) and microsatellite instability. Dis Markers 20:179\u2013180","journal-title":"Dis Markers"},{"key":"9733_CR18","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/cncr.20873","volume":"103","author":"G Ponti","year":"2005","unstructured":"Ponti G, Losi L, Di Gregorio C, Roncucci L, Pedroni M, Scarselli A et al (2005) Identification of Muir\u2013Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer 103:1018\u20131025","journal-title":"Cancer"},{"key":"9733_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/modpathol.3800997","volume":"2","author":"V Chhibber","year":"2008","unstructured":"Chhibber V, Dresser K, Mahalingam M (2008) MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir\u2013Torre syndrome. Mod Pathol 2:159\u2013164","journal-title":"Mod Pathol"},{"key":"9733_CR20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00000478-200203000-00007","volume":"26","author":"M Mathiak","year":"2002","unstructured":"Mathiak M, R\u00fctten A, Mangold E, Fischer HP, Ruzicka T, Friedl W et al (2002) Loss of DNA mismatch repair proteins in skin tumors from patients with Muir\u2013Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol 26:338\u2013343","journal-title":"Am J Surg Pathol"},{"key":"9733_CR21","unstructured":"Morales-Burgos A, S\u00e1nchez JL, Figueroa LD, De Jes\u00fas-Monge WE, Cruz-Correa MR, Gonz\u00e1lez-Keelan C et al (2008) MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms. P R Health Sci J 27:322\u2013327"},{"key":"9733_CR22","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1523-1747.2003.12125.x","volume":"120","author":"R Kruse","year":"2003","unstructured":"Kruse R, R\u00fctten A, Schweiger N, Jakob E, Mathiak M, Propping P et al (2003) Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. J Invest Dermatol 120:858\u2013864","journal-title":"J Invest Dermatol"},{"key":"9733_CR23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cdip.2007.05.001","volume":"13","author":"AJ Lazar","year":"2007","unstructured":"Lazar AJ, Lyle S, Calonje E (2007) Sebaceous neoplasia and Torre\u2013Muir syndrome. Curr Diagn Pathol 13:301\u2013319","journal-title":"Curr Diagn Pathol"},{"key":"9733_CR24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","volume":"62","author":"HF Vasen","year":"2013","unstructured":"Vasen HF, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, Mallorca group et al (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62:812\u2013823","journal-title":"Gut"},{"key":"9733_CR25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.clindermatol.2009.07.001","volume":"28","author":"CJ Ko","year":"2010","unstructured":"Ko CJ (2010) Muir\u2013Torre syndrome: facts and controversies. Clin Dermatol 28:324\u2013329","journal-title":"Clin Dermatol"},{"key":"9733_CR26","doi-asserted-by":"crossref","unstructured":"Roberts ME, Riegert-Johnson DL, Thomas BC et al (2014) A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir\u2013Torre variant of Lynch syndrome. Genet Med 6. doi: 10.1038\/gim.2014.19","DOI":"10.1038\/gim.2014.19"},{"key":"9733_CR27","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1038\/sj.jid.5700475","volume":"126","author":"G Ponti","year":"2006","unstructured":"Ponti G, Losi L, Pedroni M, Lucci-Cordisco E, Di Gregorio C, Pellacani G et al (2006) Value of MLH1 and MSH2 mutations in the appearance of Muir\u2013Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. J Invest Dermatol 126:2302\u20132307","journal-title":"J Invest Dermatol"},{"key":"9733_CR28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1399-0004.2011.01660.x","volume":"80","author":"MP Hitchins","year":"2011","unstructured":"Hitchins MP, Owens SE, Kwok CT, Godsmark G, Algar UF, Ramesar RS (2011) Identification of new cases of early-onset colorectal cancer with an MLH1 epimutation in an ethnically diverse South African cohort. Clin Genet 80:428\u2013434","journal-title":"Clin Genet"},{"key":"9733_CR29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ccr.2011.07.003","volume":"20","author":"MP Hitchins","year":"2011","unstructured":"Hitchins MP, Rapkins RW, Kwok CT, Srivastava S, Wong JJ, Khachigian LM et al (2011) Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5\u2032UTR. Cancer Cell 20:200\u2013213","journal-title":"Cancer Cell"},{"key":"9733_CR30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jaad.2010.08.023","volume":"64","author":"EA Griffard","year":"2011","unstructured":"Griffard EA, McCoppin HH, Wieberg J, Feldman M (2011) The cutaneous effects of post-transplant immunosuppression with cyclosporine in Muir\u2013Torre syndrome. J Am Acad Dermatol 64:86\u201387","journal-title":"J Am Acad Dermatol"},{"key":"9733_CR31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.critrevonc.2004.11.010","volume":"56","author":"A Andr\u00e9s","year":"2005","unstructured":"Andr\u00e9s A (2005) Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol 56:71\u201385","journal-title":"Crit Rev Oncol Hematol"},{"key":"9733_CR32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1600-0560.1997.tb01326.x","volume":"24","author":"KE Warschaw","year":"1997","unstructured":"Warschaw KE, Eble JN, Hood AF, Wolverton SE, Halling KC (1997) The Muir\u2013Torre syndrome in a black patient with AIDS: histopathology and molecular genetic studies. J Cutan Pathol 24:511\u2013518","journal-title":"J Cutan Pathol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-014-9733-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-014-9733-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-014-9733-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T23:12:26Z","timestamp":1565565146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-014-9733-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,27]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["9733"],"URL":"https:\/\/doi.org\/10.1007\/s10689-014-9733-4","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,27]]}}}